Camden National Bank’s Bristol-Myers Squibb BMY Stock Holding History

Camden National Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,814	Closed	-$221K	–	123
2023 Q3	$221K	Sell	3,814 -90	-2%	-$5.51K	0.05%	114
2023 Q2	$250K	Sell	3,904 -110	-3%	-$7.38K	0.05%	111
2023 Q1	$278K	Buy	4,014 +250	+7%	+$17.6K	0.06%	102
2022 Q4	$271K	Sell	3,764 -433	-10%	-$32.6K	0.06%	103
2022 Q3	$298K	Buy	4,197 +100	+2%	+$7.25K	0.07%	98
2022 Q2	$315K	Sell	4,097 -56	-1%	-$4.26K	0.07%	101
2022 Q1	$303K	Sell	4,153 -550	-12%	-$36.9K	0.05%	118
2021 Q4	$293K	Buy	4,703 +260	+6%	+$15.3K	0.05%	130
2021 Q3	$263K	Sell	4,443 -2,507	-36%	-$165K	0.05%	129
2021 Q2	$464K	Sell	6,950 -96	-1%	-$6.26K	0.09%	97
2021 Q1	$445K	Buy	7,046 +190	+3%	+$11.8K	0.09%	95
2020 Q4	$426K	Sell	6,856 -573	-8%	-$35.2K	0.09%	93
2020 Q3	$447K	Hold	7,429	–	–	0.1%	91
2020 Q2	$437K	Sell	7,429 -25	-0.3%	-$1.5K	0.11%	87
2020 Q1	$415K	Sell	7,454 -5	-0.1%	-$306	0.11%	85
2019 Q4	$479K	Buy	+7,459	New	+$427K	0.1%	88

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Camden National Bank's BMY Position: Q4 2023 in Review

Camden National Bank sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,814 shares — an estimated $221K sold.

Camden National Bank first reported a position in BMY in Q4 2019 and held it in 16 quarters. The position peaked at $479K in Q4 2019. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Camden National Bank reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Camden National Bank sold 3,814 Bristol-Myers Squibb shares in Q4 2023, an estimated $221K.
Camden National Bank first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 16 quarters.
Camden National Bank's Bristol-Myers Squibb position peaked at $479K in Q4 2019.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Camden National Bank's 13F filing for Q4 2023, filed 12 Feb 2024.